Effectiveness of ensitrelvir for cough caused by COVID-19 Omicron variant in patients with asthma
ABSTRACT In the post-acute coronavirus disease 2019 (COVID-19) period, patients with asthma had a significantly higher risk of cough than patients without a history of asthma. In particular, cases with persistent cough were increased during the Omicron variant epidemic. In this study, we evaluated t...
Saved in:
| Main Authors: | Naoyuki Miyashita, Nobuyuki Horita, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Tomoki Ito |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2025-05-01
|
| Series: | Microbiology Spectrum |
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/spectrum.03407-24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ensitrelvir in Hospitalized Patients with SARS-CoV-2 During the Omicron Epidemic: A Single-Center Observational Study
by: Masaya Yamato, et al.
Published: (2025-04-01) -
Therapeutic efficacy of lascufloxacin in patients with Mycoplasma pneumoniae pneumonia
by: Naoyuki Miyashita, et al.
Published: (2025-08-01) -
Drug-drug interaction between ensitrelvir and tacrolimus in a patient undergoing treatment for COVID-19: a case report
by: Yuki Miyata, et al.
Published: (2025-01-01) -
Management of Cough: a practical approach
by: M. Vally, et al.
Published: (2016-08-01) -
Cough Diagnosis: Present and Future
by: E. S. Ovsyannikov, et al.
Published: (2021-11-01)